Copyright © 2026 Authors retain the copyright of this article. This article is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

@article{188807,
        author = {Pooja Yadav},
        title = {The Role of AI Quality Control and Quality Assurance: Present and Future Perspectives},
        journal = {International Journal of Innovative Research in Technology},
        year = {2025},
        volume = {12},
        number = {7},
        pages = {4072-4078},
        issn = {2349-6002},
        url = {https://ijirt.org/article?manuscript=188807},
        abstract = {Quality Control (QC) and Quality Assurance (QA) are key elements within the pharmaceutical sector. They help to provide assurance on the safety, efficacy, and consistency of medicinal products. This article discusses the purpose of QC and QA for pharmaceutical manufacture in the modern era, outlining their development, principles, and issues relating to the application of technologies and universal quality standards. Digital technologies, specifically Artificial Intelligence (AI) and Quality by Design (QbD) in the quality system, were discussed regarding how they will shape the future of QC and QA systems in the pharmaceutical industry. The article reinforces the need for continual seamless improvement in maintaining quality system improvements that are answerable to global health standards, and that are applicable to licensed medicines in a broad range of settings, which can be efficaciously delivered to patients in a sustainable manner.},
        keywords = {Quality Control, Quality Assurance, Pharmaceuticals, GMP, QbD, AI, Future Directions},
        month = {December},
        }